ClinicalTrials.Veeva

Menu

rTMS for Adults With Autistic Spectrum Disorder

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Autism

Treatments

Device: repetitive TMS

Study type

Interventional

Funder types

Other

Identifiers

NCT01918787
NSC 100-2314-B-182A-075 (Other Identifier)
100-2985C

Details and patient eligibility

About

rTMS over dorsolateral prefrontal cortex is effective in reducing repetitive behaviors in adults with autistic spectrum disorder rTMS over posterior superior temporal sulcus is effective in improving social ability in adults with autistic spectrum disorder

Full description

First, we will apply one session intermittent theta burst stimulation over dorsolateral prefrontal cortex, posterior superior temporal sulcus and inion as control with one week interval in adults with autism spectrum disorder. Second, we will apply 5 sessions intermittent theta burst stimulation within one week over dorsolateral prefrontal cortex or posterior temporal sulcus depending on the results of our first phases.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults with autistic spectrum disorder

Exclusion criteria

  • schizophrenia
  • bipolar affective disorder
  • major depressive disorder
  • any systemic disease especially epilepsy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

repetitive TMS
Experimental group
Description:
repetitive TMS over dorsolateral prefrontal cortex, posterior superior temporal sulcus and inion as control
Treatment:
Device: repetitive TMS

Trial contacts and locations

1

Loading...

Central trial contact

Hsing Chang Ni, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems